These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 12800986

  • 1. Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy.
    Mallion JM, Carretta R, Trenkwalder P, Martinez JF, Tykarski A, Teitelbaum I, Oddou P, Fagan T, Co-Diovan Study Group.
    Blood Press Suppl; 2003 May; 1():36-43. PubMed ID: 12800986
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
    Pool JL, Glazer R, Crikelair N, Levy D.
    Clin Drug Investig; 2009 May; 29(12):791-802. PubMed ID: 19888785
    [Abstract] [Full Text] [Related]

  • 9. [Therapeutic efficacy of valsartan and valsartan/HCTZ in mild to moderate hypertensive patients].
    Sun NL, Wang HY, Zhu JR, Valsartan/HCTZ Clinical Investigation Group.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):715-8. PubMed ID: 17963629
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA, Lacourcière Y, Chiang YT, Glazer RD.
    Hypertension; 2009 Jul; 54(1):32-9. PubMed ID: 19470877
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy.
    Fogari R, Zoppi A, Mugellini A, Preti P, Destro M, Rinaldi A, Derosa G.
    Adv Ther; 2006 Jul; 23(5):680-95. PubMed ID: 17142202
    [Abstract] [Full Text] [Related]

  • 14. Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies.
    Nash DT, Crikelair N, Zappe D.
    Curr Med Res Opin; 2008 Sep; 24(9):2617-26. PubMed ID: 18687165
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy.
    Benz JR, Black HR, Graff A, Reed A, Fitzsimmons S, Shi Y.
    J Hum Hypertens; 1998 Dec; 12(12):861-6. PubMed ID: 9883710
    [Abstract] [Full Text] [Related]

  • 20. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
    Zappe D, Papst CC, Ferber P, PROMPT Investigators.
    Vasc Health Risk Manag; 2009 Dec; 5():883-92. PubMed ID: 19898644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.